#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Type IIa hyperlipidaemia Primary immunodeficiency syndrome Facioscapulohumeral muscular dystrophy Head and neck cancer Hypochondroplasia Stiff person syndrome Rett syndrome Congenital pseudarthrosis Hepatic angiosarcoma Acute myeloid leukaemia recurrent Neuropathy peripheral Congenital leptin deficiency Cutaneous T-cell lymphoma recurrent Paget's disease of the vulva More trials…

    Learn about Rare Diseases

    Leukoencephalopathy Langerhans cell sarcoma – Life with Disease Mitochondrial myopathy – Trials in Disease Glomerulonephritis rapidly progressive – Life with Disease Inclusion body myositis – Treatment Langerhans’ cell histiocytosis – Life with Disease Carcinoid syndrome – Treatment Osteosarcoma recurrent – Diagnostics Vascular malformation Pleomorphic leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triglycerides, Medium Chain Saline Ceftolozane [18F]CPFPX Carbidopa Evencaleucel Peppermint Oil Doxribtimine A24110He PETHIDINE HYDROCHLORIDE Sargramostim Dordaviprone Amantadine Hydrochloride Ocrelizumab Sabatolimab Gallium Citrate Ga-68 Filgrastim RUBIDIUM CHLORIDE Elebsiran Caffeine More therapies…

    Learn about Your Condition

    Acquired ATTR amyloidosis Lymphocyte adoptive therapy Short stature Lymphangiosarcoma Radius fracture Chronic disease Underweight Lymphangioleiomyomatosis Head injury Neuroendocrine tumour Immunodeficiency Endocarditis enterococcal Acute hepatic failure Essential thrombocythaemia Lupus nephritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Avutometinib and Defactinib with Other Treatments for Patients with Recurrent Low-Grade Serous Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Avutometinib
    • Defactinib
    • Doxorubicin Hydrochloride, Liposomal
    Belgium Denmark France Germany Ireland Italy +3

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    France Germany Greece Italy The Netherlands Poland +1

  • Study on Colon Cancer Treatment Using Disodium Levofolinate and Drug Combination for Patients with Operable Stage III and High-Risk Stage II Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer stage II
    • Colorectal cancer stage III
    Investigated Drugs:
    • Disodium Levofolinate
    • Calcium Levofolinate
    • Capecitabine
    Germany Italy Spain

  • Study Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Leiomyosarcoma
    • Leiomyosarcoma metastatic
    Investigated Drugs:
    • Trabectedin
    • Gemcitabine
    Italy

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Belgium France Germany Italy Spain

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Gemcitabine Hydrochloride
    • Mitomycin
    Austria Belgium Czechia Denmark France Germany +4

  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Germany Hungary Italy Poland +1

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on BP1.7881 for Adults with Eosinophilic Esophagitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Bp1.7881A
    France Italy

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8
Previous Page
1 … 23 24 25 26 27 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!